{
"id":"mk19_b_hm_t09",
"number":9,
"bookId":"hm",
"title":{
"__html":"Mayo Clinic Model of Risk of MGUS Progression to a Clinically Symptomatic Plasma Cell Dyscrasia"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"f7544b",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 9. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_hm_t09"
}
]
},
"Mayo Clinic Model of Risk of MGUS Progression to a Clinically Symptomatic Plasma Cell Dyscrasia"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"523223",
"class":"col hd l",
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d811a6",
"class":"col hd l",
"children":[
"Risk Factors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b97d93",
"class":"col hd l",
"children":[
"Progression"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a1d91",
"class":"cell txt l",
"children":[
"Non-light-chain MGUS (IgG, IgA, IgM)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6dad4f",
"class":"cell txt l",
"children":[
"M protein ≥1.5 g/dL"
]
},
" ",
{
"type":"p",
"hlId":"02dac6",
"class":"cell txt l",
"children":[
"Non-IgG M protein"
]
},
" ",
{
"type":"p",
"hlId":"03d436",
"class":"cell txt l",
"children":[
"Abnormal serum FLC ratio"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5303db",
"class":"cell txt l",
"children":[
"At 20 years:"
]
},
" ",
{
"type":"p",
"hlId":"74334d",
"class":"cell txt l",
"children":[
"3 RFs: 58% (high risk)"
]
},
" ",
{
"type":"p",
"hlId":"6ff2dd",
"class":"cell txt l",
"children":[
"2 RFs: 37% (high-intermediate risk)"
]
},
" ",
{
"type":"p",
"hlId":"e338e4",
"class":"cell txt l",
"children":[
"1 RF: 21% (intermediate-low risk)"
]
},
" ",
{
"type":"p",
"hlId":"6a90c7",
"class":"cell txt l",
"children":[
"0 RFs: 5% (low risk)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58c1c3",
"class":"cell txt l",
"children":[
"Smoldering myeloma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b41617",
"class":"cell txt l",
"children":[
"M protein ≥3 g/dL"
]
},
" ",
{
"type":"p",
"hlId":"33c173",
"class":"cell txt l",
"children":[
"Bone marrow plasma cells ≥10%"
]
},
" ",
{
"type":"p",
"hlId":"0d9b79",
"class":"cell txt l",
"children":[
"Serum FLC ratio <0.125 or >8 mg/dL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d2c166",
"class":"cell txt l",
"children":[
"At 5 years:"
]
},
" ",
{
"type":"p",
"hlId":"1e9f64",
"class":"cell txt l",
"children":[
"3 RFs: 76%"
]
},
" ",
{
"type":"p",
"hlId":"0a1df2",
"class":"cell txt l",
"children":[
"2 RFs: 51%"
]
},
" ",
{
"type":"p",
"hlId":"bc76fa",
"class":"cell txt l",
"children":[
"1 RF: 25%"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"FLC = free light chain; MGUS = monoclonal gammopathy of undetermined significance; RF = risk factor."
],
[
"Data adapted from Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005;106:812-17. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/15855274",
"target":"_blank"
},
"children":[
"PMID: 15855274"
]
},
" doi:10.1182/blood-2005-03-1038; and Dispenzieri A, Kyle RA, Katzmann JA, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008;111:785-9. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/17942755",
"target":"_blank"
},
"children":[
"PMID: 17942755"
]
},
" doi:10.1182/blood-2007-08-108357"
]
]
}